Memphasys Ltd - Asset Resilience Ratio

Latest as of June 2024: 0.00%

Memphasys Ltd (MEM) has an Asset Resilience Ratio of 0.00% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MEM current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

AU$12.43 Million

≈ $8.80 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Memphasys Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Memphasys Ltd assets under control.

Liquid Assets Composition Over Time

This chart breaks down Memphasys Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Memphasys Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Memphasys Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Memphasys Ltd Industry Peers by Asset Resilience Ratio

Compare Memphasys Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Memphasys Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Memphasys Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	0.00%	AU$0.00 ≈ $0.00	AU$12.43 Million ≈ $8.80 Million	--
2023-06-30	0.29%	AU$42.75K ≈ $30.25K	AU$14.67 Million ≈ $10.38 Million	-4.49pp
2018-06-30	4.79%	AU$201.81K ≈ $142.79K	AU$4.22 Million ≈ $2.98 Million	-47.63pp
2017-06-30	52.42%	AU$3.83 Million ≈ $2.71 Million	AU$7.30 Million ≈ $5.17 Million	+51.82pp
2016-06-30	0.59%	AU$42.74K ≈ $30.24K	AU$7.19 Million ≈ $5.09 Million	+0.04pp
2015-06-30	0.56%	AU$38.00K ≈ $26.89K	AU$6.84 Million ≈ $4.84 Million	--

pp = percentage points

About Memphasys Ltd

AU:MEM Australia Medical Devices

Market Cap

$13.11 Million

AU$18.52 Million AUD

Market Cap Rank

#26465 Global

#1208 in Australia

Share Price

AU$0.01

Change (1 day)

+20.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37